Matthew Plunkett Insider Profile
4 Followers
Matthew Plunkett, Chief Financial Officer at Nkarta, holds ― shares in Nkarta (Ticker: NKTX), holds ― shares in CTI BioPharma (Ticker: CTIC).
Matthew Plunkett's Trading History
| CTICCTI BioPharma | Mar 23, 2016 | ― | Uninformative Sell | 34.49K | ― | |
| NKTXNkarta | ― | Chief Financial Officer | ― | ― |
You May Also Like
Matthew Plunkett insider profile FAQ
What is the percentage of profitable transactions made by Matthew Plunkett?
The percentage of profitable transactions made by Matthew Plunkett is 100%.
What is the average return per transaction made by Matthew Plunkett?
The average return per transaction made by Matthew Plunkett is 61.70%.
What stocks does Matthew Plunkett hold?
Matthew Plunkett holds: NKTX, CTIC stocks.
What was Matthew Plunkett's most profitable transaction?
Matthew Plunkett’s most profitable transaction was an Informative Sell of CTIC stock on October 1, 2015. The return on the trade was 74.30%.
What is Matthew Plunkett's role in Nkarta?
Matthew Plunkett's role in Nkarta is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
